Suchergebnisse - "Follicular lymphoma"

PubPharm (4.290)

1

Advancements in the Management of Follicular Lymphoma : A Comprehensive Review

enthalten in: Turkish journal of haematology : official journal of Turkish Society of Haematology | 2024

von Merryman, R. | Mehtap, �. | LaCasce, A.

2

Case report : Mutation evolution in a patient with TdT positive high grade B cell lymphoma with MYC and BCL2 rearrangements following the treatment of concurrent follicular lymphoma and diffuse large B-cell lymphoma

enthalten in: Discover oncology | 2024

von Zhang, F. | Chen, Y. | Cui, Q. | +2

3

Case report: Mutation evolution in a patient with TdT positive high grade B cell lymphoma with MYC and BCL2 rearrangements following the treatment of concurrent follicular lymphoma and diffuse large B-cell lymphoma

enthalten in: Discover oncology | 2024

von Zhang, F. | Chen, Y. | Cui, Q. | +2

4

Follicular Lymphoma Presenting With Symptomatic Bone Involvement : A Clinicopathologic and Molecular Analysis of 16 Cases

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2024

von Sarro, R. | Bisig, B. | Guey, B. | +7

5

Anthropometric indicators may explain the high incidence of follicular lymphoma in Europeans : Results from a bidirectional two-sample two-step Mendelian randomisation

enthalten in: Gene | 2024

von Zhou, Y. | Zhang, X. | Li, X. | +5

6

Two recurrent types of IGH::5' BCL2 breakpoints representing cytogenetic ins(14;18)(q32;q21q21) and t(14;18)(q32;q21), mediated by the VDJ and class switch recombination processes, respectively

enthalten in: Leukemia & lymphoma | 2024

von Maekawa, F. | Hayashida, M. | Takeoka, K. | +7

7

Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma : Clinical Management Experience From a Pivotal Phase I/II Trial

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Matasar, M. | Bartlett, N. | Shadman, M. | +13

8

A case of concurrent follicular lymphoma and lung cancer requiring differentiation from lymph node metastasis

enthalten in: Thoracic cancer | 2024

von Takahara, Y. | Nagae, S. | Yamagata, A. | +4

9

Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment : A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203

enthalten in: Hematological oncology | 2024

von Watanabe, T. | Matsuno, Y. | Wakabayashi, M. | +13

10

Efficacy and safety of lenalidomide in the treatment of B-cell non-Hodgkin lymphoma

enthalten in: Discover. Oncology | 2024

von Liu, Y. | Li, Y. | Zhang, C. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[429]